Steven Hagen's role as vice president of pharmaceutical development and manufacturing has been extended to include additional responsibilities in the US and India.
Hagen will report to AMRI chairman, president and ceo Thomas D'Ambra. He will now assume leadership for AMRI's chemical development, small scale cGMP manufacturing, and large scale commercial manufacturing business components, including operations in Albany/Rensselaer and Syracuse, New York; Hyderabad, India.
He will also handle AMRI's large scale manufacturing operations in Rensselaer, New York and Aurangabad, India. Previously, Hagen's responsibilities covered analytical chemistry, quality assurance and regulatory affairs for all AMRI locations. Meanwhile, Luckner Ulysse, Jr., has been promoted to vice president of chemical development from senior director.